ABSTRACT. The feasibility of using a multiple gas rebreathing technique to evaluate cardiopulmonary function in the ventilated neonate was assessed by measuring functional residual capacity, diffusing capacity of lung for carbon monoxide, and effective pulmonary capillary blood flow in 10 neonates with respiratory distress syndrome. Measurements were first made on the level of positive end expiratory pressure (PEEP) selected by the clinicians caring for the infants ("clinical" PEEP, mean of 4.4 2 0.3 cm H20). To evaluate the effect of P E E P on cardiopulmonary function, P E E P was then changed above (mean of 6.7 f 0.4 cm H 2 0 ) and below (mean of 1.9 + 0.3 cm H 2 0 ) this level and measurements were repeated. Mean functional residual capacity on clinical P E E P (10.8 + 1.6 ml/kg) was far below the predicted normal and varied directly with changes in P E E P (mean change of 1.2 ml/kg/cm H20). Diffusing capacity of the lung for carbon monoxide on clinical P E E P was 0.04 + 0.01 ml/min/mm Hg/kg and did not change significantly with changes in PEEP. Mean effective pulmonary capillary blood flow was highest (70 ml/min/kg) a t the lowest level of PEEP. However, the effect of increasing P E E P on effective pulmonary capillary blood flow in individual infants varied. Increasing P E E P increased arterial oxygen tension but did not cause changes in systemic arterial pressure or heart rate. We conclude that infants with respiratory distress syndrome have severe lung injury with decreased functional residual capacity and diffusing capacity of the lung for carbon monoxide, and that lung volume improves with the use of PEEP. Although P E E P has a beneficial effect on arterial oxygenation, it may impair systemic oxygen transport in some infants because of its detrimental effect on cardiac output. This detrimental effect on cardiac output could not be detected by usual clinical monitoring techniques. (Pediatr Res 20: 316-320,1986) Abbreviations HDS, respiratory distress syndrome PEEP, positive end expiratory pressure FRC, functional residual capacity QCm, effective pulmonary capillary blood flow DI,CO, diffusing capacity of the lung for carbon monoxide TcP02, transcutaneous oxygen tension PAo, mean systemic arterial blood pressure
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A multiple gas rebreathing method, first introduced by Sackner et al. ( 5 ) , permits rapid, on-line, and easily repeatable measurements of several cardiopulmonary variables including FRC, QeR, and DLCO. This technique has already been shown to be accurate and reproducible in animal studies of lung injury (6) and in adult human studies (7) . Recently, we have shown that this technique provides an accurate measurement of cardiopulmonary function in mechanically ventilated piglets, comparable in size to the human neonate, including piglets with oleic-acid induced lung injury ventilated using PEEP (8) .
The purpose of this study was to evaluate the feasibility of using this rebreathing methodology to measure cardiopulmonary function in mechanically ventilated human neonates with RDS. In addition, we also utilized the rebreathing technique to investigate the effect of PEEP on cardiopulmonary function.
METHODS
The study population consisted of 10 infants admitted to the Neonatal Intensive Care Unit at North Carolina Memorial Hospital with severe RDS diagnosed by clinical and radiographic features (9) . Informed consent was obtained from the parents prior to the study. At the time of entry into the study, all infants were intubated with uncuffed endotracheal tubes and ventilated with pressure-limited, time-cycled ventilators (BP 200 or Bear Cub, Bear Medical Systems, Inc., Riverside, CA) using intermittent mandatory ventilation and PEEP. The initial ventilator settings had been selected by the clinicians caring for the infants (not members of the investigative team) by criteria based primarily on the results of arterial blood gas analyses. The level of PEEP at the time of enrollment into the study is termed the "clinical" PEEP level. The study population is described in Table 1 .
Measurements of cardiopulmonary function were made using (8) . The rebreathing apparatus consisted of a 50 ml rubber bag-in-bottle and valve (total dead space of two ml) originally developed by Gallioto el al. (10) . The valve was interposed between the endotracheal tube and the ventilator. On turning the valve the inspiratory gas flow from the ventilator could be rapidly diverted to the bag-in-bottle system allowing the infant to be rebreathed with a mixture of test gases contained in the bag. Between measurements the infant was ventilated directly by the ventilator through the valve. The test gas mixture contained 0.3% C1'O, 0.6% C2H2, 10% He, and a percentage of oxygen that was 10% higher than the inspired oxygen concentration being used prior to the measurements. The balance of the test gas mixture was NZ The rebreathing volume used was 15 to 20 ml/kg. Rebreathing was begun at the end of a normal expiration and continued at a rate of 40 breathslmin for 30 s. During rebreathing, gentle pressure was applied externally to the trachea to prevent air leakage. This technique eliminated leaks around the endotracheal tube that could be detected by auscultation and produced a flat helium curve after the point of complete mixing between the lung and the rebreathing bag, suggesting that the system remained closed during the measurement period. The gases were continuously sampled at the airway opening by a mass spectrometer (MGA 1100, Perkin Elmer Corp., Pomona, CA; sampling rate of 15 ml/min). The analog signals from the mass spectrometer were directed to a microcomputer (MINC/I 1, Digital Equipment Corp., Maynard, MA). The computer calculated the slope of the disappearance curves of C1'O and C2H2, correcting for the He dilution, after the point of minimal oscillation of the He tracing ( Fig. 1 ). Data were analyzed for three consecutive breaths after this starting point using the algorithm of Sackner et al. (5) . Sampling resulted in a linear loss of volume of gas in the lungs and test gas bag during the measurement period. The magnitude of this loss was approximately 5 to 7% at the point of data analysis. No correction was made for this loss. Rebreathing measurements were done in triplicate and averaged (6) . The total time required to obtain and analyze the data was approximately 1 min. Most infants exhibited some spontaneous respiratory effort during the rebreathing measurements. However, their spontaneous tidal volumes were much smaller than the rebreathing volumes used and therefore did not affect the interpretation of gas disappearance curves. TcP02, PAo, and end-tidal C 0 2 were also monitored in all infants throughout the experiments.
Rebreathing measurements, TcP02 and PAo values were initially obtained at the respiratory settings chosen by the clinicians (clinical PEEP, Table 1 ). PEEP was then either increased or decreased by 2 to 3 cm H 2 0 in a random fashion. After a period of approximately 20 min, all measurements were repeated. PEEP was then changed in the opposite direction 2 to 3 cm H 2 0 above or below the clinical PEEP level and measurements were again repeated after a 20-min period. Since the rebreathing measurement begins at end-expiration in a closed system, the rebreathing method would not increase end-expiratory pressure.
Six infants were studied at all three levels of PEEP. Because of external constraints, measurements could only be made at two PEEP levels in three additional infants. Another infant developed an erratic breathing pattern on the PEEP level above clinical PEEP, prohibiting the precise determination of the time of endexhalation and accurate timing of the switching of the rebreathi ng valve. Measurements, therefore, were not made in this infant at the higher PEEP level. One of the infants was studied on 2 consecutive days. The results of measurements made on the 2nd day in this infant are reported separately.
Statistical analyses were performed using the Student's t test for paired variables to compare values at different levels of PEEP.
Values for p < 0.05 were considered to be significant. All data are expressed as the mean + SEM. Table 1 describes the study population and the level of ventilatory support at the time of enrollment into the study. The average F102 was 0.5 1 k 0.04 with one infant requiring an F102 greater than 0.70. No patient was ventilated at a peak airway pressure greater than 28 cm H 2 0 (average peak airway pressure of 23 cm H20). The average level of clinical PEEP was 4.4 + 0.3 cm H 2 0 (range 3 to 5 cm H20).
RESULTS
There appeared to be no adverse effects of making repeated rebreathing measurements in these infants. No decreases in TcP02 occurred during the 30-s measurement periods. In fact, transient small increases in TcP02 were often observed during the rebreathing period due to the higher concentration of oxygen in the test gas mixture compared to that being delivered by the 318
-s rebreathing period, due to the fact that the patient was rebreathing in a closed system, but rapidly returned to baseline levels within the first few breaths after the valve was returned to the ventilator mode position. No changes in heart rate, PAo, or airway pressure were observed during or between individual measurements. We have performed over 100 rebreathing measurements in neonates with RDS and have encountered no adverse clinical complications including evidence of barotrauma, changes in systemic arterial pressure, or impairment of oxygenation.
Values for rebreathing variables, TcP02 and PAo obtained at the initial clinical PEEP levels and the effects of changing the levels of PEEP are shown in Table 2 . Data for TcP02 and PAo were obtained just prior to each rebreathing measurement. The average TcP02 at the clinical level of PEEP was 92 mm Hg. Decreasing PEEP from the clinical level (average of 2.5 cm H20) resulted in a significant decrement in TcP02 (mean decrease of 24%). Increasing PEEP above the clinical PEEP level (average of 2.3 cm H20) resulted in a numerically higher TcP02 (average increase of 13%) but this increase was not significant. No significant changes in PAo or heart rate occurred when the PEEP level was either increased or decreased (data not shown).
At the clinical level of PEEP, the average value for FRC was 10.8 ml/kg, for DLCO was 0.04 ml/min/mm Hg/kg, and for Q,r was 62 ml/min/kg. Increasing the level of PEEP resulted in a significant rise in FRC (mean increase of 37%). Lowering the level of PEEP caused a significant decrease in FRC (mean decrease of 34%). There was no effect of changes in PEEP in DLCO. However, DLCO per unit lung volume decreased with increasing levels of PEEP.
The effect of PEEP on Q ,~ varied. Qer was significantly the highest at the lowest level of PEEP (mean of 70 ml/min/kg). The values for Q ,~ at the clinical PEEP level averaged 77% of the values at the lower level.of PEEP. However, only six of nine infants had an increase in Qer of (average of 44%) when PEEP was dropped below clinical PEEP. There was no change in one Table 2 . Cardiopulmonary function infant and a decrease of 26% in Q, N in the other two infants. Mean Q,r did not change significantly when PEEP was elevated above the clinical PEEP level. Only one of seven infants studied had a decrement in Qer when PEEP was raised above clinical PEEP.
There appeared to be a relationship between the changes in Qer and FRC. Q, n increased (average of 33%) when PEEP was elevated above the clinical level in three infants. These infants had extremely low FRC values (average of 6.3 ml/kg) at the clinical PEEP level. One additional infant with a similar FRC (5.3 ml/kg) had no change in Q,r when PEEP was increased. In the remaining three infants studied at the highest PEEP level (average FRC of 16.8 ml/kg on clinical PEEP), Qeff either decreased or remained unchanged when PEEP was increased above the clinical level. Changes in Q,r at any PEEP level were not associated with changes in either heart rate or systemic blood pressure.
Patient 7 was studied serially on the 1st and 2nd days of life. Between the study days, there was obvious clinical improvement as evidenced by an improvement in oxygenation (decrease in F102 from 0.7 1 to 0.65 and increase in Pao2/F~02 ratio from 1 16 to 155) on a lower clinical PEEP level (5 to 4 cm H20). This clinical improvement was corroborated by rebreathing measurements with an increase in FRC (7.6 to 13.6 ml/kg) and DLCO (.02 to .03 ml/min/mm Hg/kg) on the clinical PEEP level from the first day compared to the 2nd study day (Table 3) . No change in Q, n at the clinical PEEP level occurred between study days. Increasing PEEP above the clinical level 5 to 7 cm H 2 0 caused an increase in Q, g of 62% on the 1st study day. A .similar increase in PEEP on the 2nd day caused a decrease in QeNof 19%.
The average coefficient of variation for repeated measurements in all subjects at all PEEP levels were FRC 14 + 2%, QCN 18 t 2%, and DLCO 23 k 3%. Rebreathing methodology has also been used to measure lung water (1 I). However, because of the diffuse heterogeneous nature of the lung injury in these infants, highly reproducible measurements of lung water could not be obtained and are therefore not reported. decrements in cardiac output. Similarly, decrements in cardiac output during a period of observation longer than in the current study may result in the development of metabolic acidosis or decreased urine production. However, significant decrements in QCf1-and total cardiac output with increasing levels of PEEP, resulting in decrements in systemic oxygen transport, may be immediately detectable only by the use of the rebreathing methodology.
Measurement o f Q~~ by rebreathing has been demonstrated, by comparison to dye and thcrmal dilution techniques, to be a very reliable estimate o f cardiac output in a variety o f laboratory models, including normal piglets (8), dogs ( 1 I), and human adults (12). Measurement o f cardiac output by this method assumes homogeneous ventilation to volume, ventilation to perfusion, and perfusion to volume distributions. Certainly nonuniform distribution o f ventilation and perfusion would be expected in the neonates with RDS studied. However, accurate estimates o f various rebreathing parameters have also been demonstrated in laboratory models o f abnormal ventilation to perfusion distribution within the lung, similar to those which might be expected in infants with RDS (8, 1 I ) . Friedman et a/. ( I 1 ) observed no effect o f profound alterations in perfusion following unilateral pulmonary artery occlusion on the measurement o f Qeff compared with total cardiac output measured by dye dilution in ventilated dogs ( I I ) . Similarly, maldistribution o f ventilation does not appear to effect the accuracy o f
We conclude that the multiple gas rebreathing technique provides a rapid and safe method for assessing cardiopulmonary function in the ventilated newborn infant. With this technique, effects of various mechanical ventilator modes, e.g. PEEP, can be serially evaluated which may not be as easily or accurately assessed by other monitoring techniques. Furthermore, commonly used levels of PEEP may cause clinically inapparent compromise in cardiac output. Measurement of cardiopulmonary function by rebreathing methodology may assist the clinician in providing optimal tissue oxygenation at the lowest possible lcvels of PEEP.
